- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0024843

Megakem Pharmaceuticals Private Limited
About Megakem Pharmaceuticals Private Limited
Data last updated:
Megakem Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 26 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC377620.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manisha Kumari and Meera Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 17 Sf Pvt F.No.2 Block D Chanakya Place Uttam Nagar New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.64 Lakh, a growth of 80% compared to the previous year. For the same year it recorded a net loss of ₹2.54 Lakh (net margin -13%) and EBITDA of -₹2.54 Lakh (EBITDA margin -13%). Revenue has grown at a compounded annual rate (CAGR) of 114% over three years.
Megakem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0024843).
Company details
Recognitions & Rankings of Megakem Pharmaceuticals
Contact details
Megakem Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressD – 17 Sf Pvt F.No.2 Block D Chanakya Place Uttam Nagar New Delhi, Delhi, India – 110059
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Megakem Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Megakem Pharmaceuticals Private Limited, buy the company report.
Financials of Megakem Pharmaceuticals Private Limited
FY 2025 filings availableMegakem Pharmaceuticals Private Limited reported revenue of ₹19.64 Lakh (up 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 114% over three years, including 80% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13% | ||||
| Net Profit Margin | -13% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Megakem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Megakem Pharmaceuticals Private Limited
Megakem Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Kumari | Director | 26 Feb 2021 | 5 Years 8 Months | Current |
| Meera Singh | Director | 26 Feb 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Megakem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Megakem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Megakem Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Megakem Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manisha Kumari was appointed as Director on 26 Feb 2021.
Frequently asked questions
Megakem Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 26 February 2021 (5+ years old) and is registered under CIN U51909DL2021PTC377620.
Megakem Pharmaceuticals has 2 current directors:
- Manisha Kumari - Director
- Meera Singh - Director
The latest financial statements of Megakem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Megakem Pharmaceuticals is U51909DL2021PTC377620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Megakem Pharmaceuticals was incorporated on 26 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Manisha Kumari was appointed as Director on 26 Feb 2021. Meera Singh was appointed as Director on 26 Feb 2021.
Yes, Megakem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0024843).
The registered office of Megakem Pharmaceuticals is at D – 17 Sf Pvt F.No.2 Block D Chanakya Place Uttam Nagar New Delhi, Delhi, India – 110059.
Megakem Pharmaceuticals operates in the trading industry, in the specialty segment.
Megakem Pharmaceuticals can be reached at its registered office: D – 17 Sf Pvt F.No.2 Block D Chanakya Place Uttam Nagar New Delhi, Delhi, India – 110059.

